AU2003274655A1 - Pharmaceutical compositions containing venlafaxine - Google Patents

Pharmaceutical compositions containing venlafaxine

Info

Publication number
AU2003274655A1
AU2003274655A1 AU2003274655A AU2003274655A AU2003274655A1 AU 2003274655 A1 AU2003274655 A1 AU 2003274655A1 AU 2003274655 A AU2003274655 A AU 2003274655A AU 2003274655 A AU2003274655 A AU 2003274655A AU 2003274655 A1 AU2003274655 A1 AU 2003274655A1
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
compositions containing
containing venlafaxine
venlafaxine
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003274655A
Other versions
AU2003274655A8 (en
Inventor
Avi Avramoff
Mila Gomberg
Adel Penhasi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dexcel Pharma Technologies Ltd
Original Assignee
Dexcel Pharma Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/280,084 external-priority patent/US6703044B1/en
Application filed by Dexcel Pharma Technologies Ltd filed Critical Dexcel Pharma Technologies Ltd
Publication of AU2003274655A8 publication Critical patent/AU2003274655A8/en
Publication of AU2003274655A1 publication Critical patent/AU2003274655A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
AU2003274655A 2002-10-25 2003-10-23 Pharmaceutical compositions containing venlafaxine Abandoned AU2003274655A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/280,084 2002-10-25
US10/280,084 US6703044B1 (en) 2002-10-25 2002-10-25 Venlafaxine formulations
IL158,493 2003-10-20
IL15849303A IL158493A0 (en) 2002-10-25 2003-10-20 Pharmaceutical compositions containing venlafaxine
PCT/IL2003/000862 WO2004037226A2 (en) 2002-10-25 2003-10-23 Pharmaceutical compositions containing venlafaxine

Publications (2)

Publication Number Publication Date
AU2003274655A8 AU2003274655A8 (en) 2004-05-13
AU2003274655A1 true AU2003274655A1 (en) 2004-05-13

Family

ID=32178938

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003274655A Abandoned AU2003274655A1 (en) 2002-10-25 2003-10-23 Pharmaceutical compositions containing venlafaxine

Country Status (4)

Country Link
EP (1) EP1558222A2 (en)
AU (1) AU2003274655A1 (en)
CA (1) CA2503380A1 (en)
WO (1) WO2004037226A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0418283A (en) * 2004-02-04 2007-05-02 Alembic Ltd prolonged release formulation and process for preparing an extended release formulation
US20090175934A1 (en) * 2006-03-08 2009-07-09 Jubilant Organosys Ltd. Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
CN103079596B (en) * 2010-08-31 2015-08-19 东丽株式会社 The coating materials of pharmaceutical solid preparation, medicine film preparation and coating medicine solid preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
AU2002217373A1 (en) * 2002-01-03 2003-07-15 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine

Also Published As

Publication number Publication date
AU2003274655A8 (en) 2004-05-13
CA2503380A1 (en) 2004-05-06
WO2004037226B1 (en) 2004-09-10
WO2004037226A2 (en) 2004-05-06
EP1558222A2 (en) 2005-08-03
WO2004037226A3 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
IL158493A0 (en) Pharmaceutical compositions containing venlafaxine
AU2003291103A1 (en) Pharmaceutical composition
AU2002363361A1 (en) Pharmaceutical compositions containing oxybutynin
GB2389530B (en) Pharmaceutical compositions
AU2003302603A1 (en) Improved opioid pharmaceutical compositions
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2002217373A1 (en) Controlled release pharmaceutical formulation containing venlafaxine
AU2003276549A1 (en) Pharmaceutical compositions containing a biguanide-glitazone combination
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003250372A1 (en) Pharmaceutical composition
GB2391473B (en) Pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
IL153098A0 (en) Pharmaceutical compositions containing modafinil
GB0213481D0 (en) Pharmaceutical compositions
AU2003284460A1 (en) Medicinal composition
AU2003208621A1 (en) A pharmaceutical composition
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003274655A1 (en) Pharmaceutical compositions containing venlafaxine
AU2003280799A1 (en) Medicinal composition
AU2003302320A1 (en) Seterocyclic quinones as pharmaceutical agents
AU2003280678A1 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AUPS188302A0 (en) Pharmaceutical composition
AUPS317302A0 (en) Metastable pharmaceutical compositions
AU2002335161A1 (en) Medicinal composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase